iSERA Lifesciences Approves Allotment of 1.61 Cr Equity Shares

iSERA Lifesciences Ltd (formerly Covidh Technologies Limited) announced that its Board of Directors, in a meeting held on October 01, 2026, approved the allotment of 1,61,82,800 fully paid-up equity shares. These shares, with a face value of ₹10 each, were issued at a price of ₹48.20 per share, including a premium of ₹38.20. The allotment is on a preferential basis via Share Swap at a 1:1 ratio with iSERA Biological Limited. This follows the Board's earlier approval on April 21, 2026, and subsequent shareholder approval via postal ballot/e-voting declared on May 21, 2026. BSE granted its in-principle approval on September 18, 2026. The shares are allotted to individuals categorized under Promoter and Non-Promoter groups.